This inventor holds 1 USPTO granted patent and 2 published patent applications. Top assignee: Eleusis Therapeutics US, Inc.. Active years: 2021.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2021
Title: John Bryan Clifton: Innovator in Ketamine Treatment
Introduction
John Bryan Clifton is a notable inventor based in San Antonio, TX (US). He has made significant contributions to the field of medical treatment, particularly in addressing depression and pain management. His innovative approach combines established medications in a novel way to enhance patient outcomes.
Latest Patents
John Bryan Clifton holds a patent for a method of treatment involving ketamine infusion. This method includes the administration of a first preparation comprising an antiemetic agent, preferably ondansetron, followed by a second preparation of a synergistic combination of ketamine and a benzodiazepine, preferably lorazepam. This treatment is administered via a continuous intravenous infusion. The aim of this method is to better alleviate symptoms of depression and pain, potentially reducing the need for other medications. He has 1 patent to his name.
Career Highlights
Clifton is associated with Eleusis Therapeutics US, Inc., where he applies his expertise in developing innovative treatment methods. His work focuses on improving the quality of life for patients suffering from mental health issues and chronic pain.
Collaborations
Some of his notable coworkers include J Cannon Clifton and Mark Alan Moran. Their collaborative efforts contribute to the advancement of therapeutic techniques in the medical field.
Conclusion
John Bryan Clifton's innovative work in the treatment of depression and pain through ketamine infusion showcases his commitment to improving patient care. His contributions to medical science are paving the way for more effective treatment options.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile